These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2967737)

  • 41. In vitro activity of SK&F 104662, a new glycopeptide antibiotic.
    Yao JD; Eliopoulos GM; Moellering RC
    Antimicrob Agents Chemother; 1989 Jun; 33(6):965-7. PubMed ID: 2548444
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endophthalmitis: gram positive ethiological agents and susceptibility to glycopeptides.
    Chisari G
    Curr Clin Pharmacol; 2008 Sep; 3(3):153-5. PubMed ID: 18781901
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative in vitro activities of teicoplanin, vancomycin, oxacillin, and other antimicrobial agents against bacteremic isolates of gram-positive cocci.
    Gorzynski EA; Amsterdam D; Beam TR; Rotstein C
    Antimicrob Agents Chemother; 1989 Nov; 33(11):2019-22. PubMed ID: 2532875
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Technical factors influencing the bactericidal activity of teicoplanin against staphylococci.
    Pasticci MB; Moretti A; Frongillo RF; Baldelli F; Moretti MV; Pauluzzi S
    Boll Ist Sieroter Milan; 1989; 68(2):101-7. PubMed ID: 2535247
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activity of mersacidin, a novel peptide, compared with that of vancomycin, teicoplanin, and daptomycin.
    Niu WW; Neu HC
    Antimicrob Agents Chemother; 1991 May; 35(5):998-1000. PubMed ID: 1649577
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antianaerobe activity of RBX 7644 (ranbezolid), a new oxazolidinone, compared with those of eight other agents.
    Ednie LM; Rattan A; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1143-7. PubMed ID: 12604558
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interaction of teicoplanin with other antimicrobial agents against gram-positive aerobes.
    Watt B
    J Antimicrob Chemother; 1989 Apr; 23(4):657-8. PubMed ID: 2526113
    [No Abstract]   [Full Text] [Related]  

  • 48. Synthesis and study of antibacterial activities of antibacterial glycopeptide antibiotics conjugated with benzoxaboroles.
    Printsevskaya SS; Reznikova MI; Korolev AM; Lapa GB; Olsufyeva EN; Preobrazhenskaya MN; Plattner JJ; Zhang YK
    Future Med Chem; 2013 Apr; 5(6):641-52. PubMed ID: 23617428
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro activity of decaplanin (M86-1410), a new glycopeptide antibiotic.
    Sanchez ML; Wenzel RP; Jones RN
    Antimicrob Agents Chemother; 1992 Apr; 36(4):873-5. PubMed ID: 1386973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Microbiological-clinical study on the efficacy of a new antibiotic: teicoplanin].
    Martinetto P; Gariglio M; Malcangi A; Cavallo GP
    G Batteriol Virol Immunol; 1985; 78(1-6):86-94. PubMed ID: 2943627
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro activity of teichomycin and vancomycin alone and in combination with rifampin.
    Varaldo PE; Debbia E; Schito GC
    Antimicrob Agents Chemother; 1983 Mar; 23(3):402-6. PubMed ID: 6221692
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A40926, a new glycopeptide antibiotic with anti-Neisseria activity.
    Goldstein BP; Selva E; Gastaldo L; Berti M; Pallanza R; Ripamonti F; Ferrari P; Denaro M; Arioli V; Cassani G
    Antimicrob Agents Chemother; 1987 Dec; 31(12):1961-6. PubMed ID: 2964225
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro activities of daptomycin (LY146032) and paldimycin (U-70,138F) against anaerobic gram-positive bacteria.
    Chow AW; Cheng N
    Antimicrob Agents Chemother; 1988 May; 32(5):788-90. PubMed ID: 2840019
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro activity of the new glycopeptide LY333328 against multiply resistant gram-positive clinical isolates.
    García-Garrote F; Cercenado E; Alcalá L; Bouza E
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2452-5. PubMed ID: 9736584
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Teichomycin: in-vitro and in-vivo evaluation in comparison with other antibiotics.
    Pallanza R; Berti M; Goldstein BP; Mapelli E; Randisi E; Scotti R; Arioli V
    J Antimicrob Chemother; 1983 May; 11(5):419-25. PubMed ID: 6223907
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [In vitro activity of a new glycopeptide antibiotic eremomycin in relation to obligate anaerobic Gram-positive bacteria].
    Malkova IV; Borisova OK; Pavlova MV; Zemlianitskaia EP; Sergeeva TI
    Antibiot Khimioter; 1991 Apr; 36(4):17-20. PubMed ID: 1654046
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A study of the possible interactions between human platelets and the antibiotic MDL-507 (teicoplanin).
    Porta M; Ricchetti I
    Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):661-4. PubMed ID: 2950065
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New semisynthetic teicoplanin derivatives have comparable in vitro activity to that of oritavancin against clinical isolates of VRE.
    Szűcs Z; Ostorházi E; Kicsák M; Nagy L; Borbás A; Herczegh P
    J Antibiot (Tokyo); 2019 Jul; 72(7):524-534. PubMed ID: 30874609
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antimicrobial glycopeptides: synthesis and antibacterial activity of N-linked and O-linked smaller chain glycopeptides.
    Nagarajan K; Taleuzzamman M; Kumar V; Singh S; Singh J; Panda BP; Ghosh LK
    Drug Res (Stuttg); 2014 Apr; 64(4):186-94. PubMed ID: 24026960
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.
    Campoli-Richards DM; Brogden RN; Faulds D
    Drugs; 1990 Sep; 40(3):449-86. PubMed ID: 2146108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.